Portfolio company
Momentous Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ProteoValent Therapeutics
This company develops targeted protein degrader therapies for cancer and haematology patients.
Accent Therapeutics
This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.
KyDo Therapeutics
This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.
PanCancerT
This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
THERAtRAME
The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.
Cold Start Therapeutics
This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.
Chromacure
This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.